Albemarle Preferred Stock, Shares Outstanding remained flat by 0.0% to $2.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $2.30M to $2.30M.
An increase indicates the issuance of new preferred equity, while a decrease signals share repurchases or conversions into common stock.
This metric quantifies the total number of preferred stock shares currently held by all shareholders, excluding treasury...
Most large-cap pharmaceutical companies have simplified capital structures, so this is often zero or very low compared to common share counts.
other_preferred_stock_shares_outstanding| Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $2.30M | $2.30M | $2.30M | $2.30M | $2.30M | $2.30M | $2.30M | $2.30M | $2.30M |
| QoQ Change | — | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |